Ichor Medical Systems Incorporated   Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (1994)
Status: Defunct (2004)

Organization Overview

First Clinical Trial
2000
NCT00027521
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 1)

Encephalomyelitis, Equine (Phase 1)

Encephalomyelitis, Venezuelan Equine (Phase 1)

Fever (Phase 2)

Head and Neck Neoplasms (Phase 1)

Hemorrhagic Fevers, Viral (Phase 2)

Hemorrhagic Fever with Renal Syndrome (Phase 2)

HIV Infections (Phase 1)

Melanoma (Phase 1)

Pancreatic Neoplasms (Phase 1)

Syndrome (Phase 2)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 10